INTRODUCTION: Previous work led to our hypothesis that sex differences produced by nicotine withdrawal are modulated by stress and dopamine systems in the nucleus accumbens (NAcc). We investigated our hypothesis by studying intact females to determine whether the mechanisms that promote withdrawal are ovarian-hormone mediated. METHODS: Female rats were ovariectomized (OVX) or received sham surgery (intact) on postnatal day (PND 45-46). On PND 60, they received sham surgery (controls) or were prepared with nicotine pumps. Fourteen days later, half of the rats had their pumps removed (nicotine withdrawal) and the other half received sham surgery (nicotine exposure). Twenty-four hours later, the rats were tested for anxiety-like behavior using the elevated plus maze and light/dark transfer procedures. The NAcc was then dissected for analysis of several genes related to stress (CRF, UCN, CRF-R1, CRF-R2, CRF-BP, and Arrb2) or receptors for dopamine (Drd1 and Drd2) and estradiol (Esr2). RESULTS: During withdrawal, intact females displayed an increase in anxiety-like behavior in both tests and CRF, UCN, and Drd1 gene expression. During nicotine exposure, intact females displayed a decrease in CRF-R1, CRF-R2, Drd3, and Esr2 gene expression and an increase in CRF-BP. This pattern of results was absent in OVX females. CONCLUSIONS: Nicotine withdrawal produced an increase in anxiety-like behavior and stress-associated genes in intact females that is distinct from changes produced by nicotine exposure. The latter effects were absent in OVX females, suggesting that stress produced by withdrawal is ovarian-hormone mediated. These findings have important implications towards understanding tobacco use liability among females.
INTRODUCTION: Previous work led to our hypothesis that sex differences produced by nicotine withdrawal are modulated by stress and dopamine systems in the nucleus accumbens (NAcc). We investigated our hypothesis by studying intact females to determine whether the mechanisms that promote withdrawal are ovarian-hormone mediated. METHODS: Female rats were ovariectomized (OVX) or received sham surgery (intact) on postnatal day (PND 45-46). On PND 60, they received sham surgery (controls) or were prepared with nicotine pumps. Fourteen days later, half of the rats had their pumps removed (nicotine withdrawal) and the other half received sham surgery (nicotine exposure). Twenty-four hours later, the rats were tested for anxiety-like behavior using the elevated plus maze and light/dark transfer procedures. The NAcc was then dissected for analysis of several genes related to stress (CRF, UCN, CRF-R1, CRF-R2, CRF-BP, and Arrb2) or receptors for dopamine (Drd1 and Drd2) and estradiol (Esr2). RESULTS: During withdrawal, intact females displayed an increase in anxiety-like behavior in both tests and CRF, UCN, and Drd1 gene expression. During nicotine exposure, intact females displayed a decrease in CRF-R1, CRF-R2, Drd3, and Esr2 gene expression and an increase in CRF-BP. This pattern of results was absent in OVX females. CONCLUSIONS:Nicotine withdrawal produced an increase in anxiety-like behavior and stress-associated genes in intact females that is distinct from changes produced by nicotine exposure. The latter effects were absent in OVX females, suggesting that stress produced by withdrawal is ovarian-hormone mediated. These findings have important implications towards understanding tobacco use liability among females.
Authors: E C Donny; A R Caggiula; P P Rowell; M A Gharib; V Maldovan; S Booth; M M Mielke; A Hoffman; S McCallum Journal: Psychopharmacology (Berl) Date: 2000-09 Impact factor: 4.530
Authors: I J Karolyi; H L Burrows; T M Ramesh; M Nakajima; J S Lesh; E Seong; S A Camper; A F Seasholtz Journal: Proc Natl Acad Sci U S A Date: 1999-09-28 Impact factor: 11.205
Authors: R L Bell; M W Kimpel; Z A Rodd; W N Strother; F Bai; C L Peper; R D Mayfield; L Lumeng; D W Crabb; W J McBride; F A Witzmann Journal: Alcohol Date: 2006-08 Impact factor: 2.405
Authors: Kevin P Uribe; Victor L Correa; Briana E Pinales; Rodolfo J Flores; Bryan Cruz; Zhiying Shan; Adriaan W Bruijnzeel; Arshad M Khan; Laura E O'Dell Journal: Neuropsychopharmacology Date: 2019-10-15 Impact factor: 7.853
Authors: Rodolfo J Flores; Joseph A Pipkin; Kevin P Uribe; Adriana Perez; Laura E O'Dell Journal: Behav Brain Res Date: 2016-04-06 Impact factor: 3.332
Authors: Aimee L McRae-Clark; Angie M Cason; Amy S Kohtz; Megan Moran Santa-Maria; Gary Aston-Jones; Kathleen T Brady Journal: J Neurosci Res Date: 2017-01-02 Impact factor: 4.164
Authors: Victor L Correa; Rodolfo J Flores; Luis M Carcoba; Montserrat C Arreguin; Laura E O'Dell Journal: Neuropharmacology Date: 2019-07-17 Impact factor: 5.250
Authors: Rodolfo J Flores; Bryan Cruz; Kevin P Uribe; Victor L Correa; Montserrat C Arreguin; Luis M Carcoba; Ian A Mendez; Laura E O'Dell Journal: Psychoneuroendocrinology Date: 2020-05-05 Impact factor: 4.905
Authors: Steven T Pittenger; Natashia Swalve; Shinnyi Chou; Misty D Smith; Amanda J Hoonakker; Cindy M Pudiak; Annette E Fleckenstein; Glen R Hanson; Rick A Bevins Journal: Synapse Date: 2016-05-04 Impact factor: 2.562